Treatment of muscular dystrophy with cord blood cells
US7452529B2 · kind B2 · utility
23Cited by
3References
1Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 23, 2002 |
| Grant date | Nov 18, 2008 |
| Priority date | — |
| Expiry date | Jul 23, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P21/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features methods for treating a patient suffering from muscular dystrophy by administration of umbilical cord blood cells, e.g., by IV infusion.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.